Funding for this research was provided by:
Galderma
Article History
Received: 29 November 2023
Accepted: 22 December 2023
First Online: 19 January 2024
Declarations
:
: Amy Poteate and JP York work for Galderma. Ofra Levy-Hacham is an employee of Sol–Gel Technologies.
: Ethics committee approval was not required because this article only details collected pharmacovigilance data from real-world use.